## KMI: Kinder Morgan, Inc. - XLE: Energy

### Executive Summary

No thesis match: MRS_10 0.3% below STRENGTH zone (3.0-6.0%); PEG 2.18 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($25.68)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 1)

**1. Kinder Morgan, Inc. $KMI Stock Holdings Raised by Westwood Holdings Group Inc.**
- Source: MarketBeat | 20251214T140835 | Bullish | Relevance: 100%
- Westwood Holdings Group Inc. increased its stake in Kinder Morgan, Inc. (NYSE:KMI) by 9.6% to over 7 million shares, making it their fifth-largest holding. Institutional investors collectively own about 62.5% of KMI stock, with significant new positions from Norges Bank and a considerable holding by Vanguard Group Inc. The article also details recent insider buying, including Chairman Richard D. Kinder's purchase of 1 million shares, as well as analyst ratings, financial performance, and dividend information for Kinder Morgan.

**2. Kinder Morgan's Biggest Problem, And Why I'm Betting On ONEOK Instead**
- Source: Seeking Alpha | 20251215T120846 | Bearish | Relevance: 94%
- This article compares two blue-chip midstream C-corporations, ONEOK (OKE) and Kinder Morgan (KMI), both known for their strong credit ratings and stable cash flows. The author, Samuel Smith, details why he believes KMI is currently overrated by the market and why OKE presents a compelling "strong buy" opportunity. He explains his decision to include ONEOK in his portfolio over Kinder Morgan.

**3. Pitcairn Co. Sells 2,477 Shares of Intuitive Surgical, Inc. $ISRG**
- Source: MarketBeat | 20251214T115247 | Neutral | Relevance: 65%
- Pitcairn Co. reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 14.9% during the second quarter, selling 2,477 shares and bringing its total holdings to 14,132 shares valued at $7.68 million. Other institutional investors also adjusted their positions in ISRG, while company insiders recently sold shares totaling over $15 million. Analysts maintain a "Moderate Buy" rating for Intuitive Surgical with an average price target of $608.79.

**4. Banque Transatlantique SA Acquires 18,345 Shares of Intuitive Surgical, Inc. $ISRG**
- Source: MarketBeat | 20251213T090847 | Neutral | Relevance: 64%
- Banque Transatlantique SA increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 15.8% in Q2, acquiring an additional 18,345 shares and bringing its total holdings to 134,669 shares valued at $73.5 million. Other institutional investors like Vanguard Group Inc. and State Street Corp also significantly modified their holdings. The article also details recent insider stock sales and analyst ratings for Intuitive Surgical.

**5. Silicon Valley Capital Partners Sells 17,540 Shares of Intuitive Surgical, Inc. $ISRG**
- Source: MarketBeat | 20251215T125232 | Neutral | Relevance: 64%
- Silicon Valley Capital Partners significantly reduced its stake in Intuitive Surgical, selling 17,540 shares, yet institutional investors still hold approximately 83.64% ownership. Despite insider selling, Intuitive Surgical reported strong Q2 earnings, surpassing analyst estimates for both EPS and revenue. Analysts currently maintain a "Moderate Buy" consensus rating for ISRG with a price target of $608.79.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 3 ($26.08M) |
| Sells | 4 ($0.51M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 33.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 9.3% (+0.4%)
- Blackrock Inc.: 7.9% (+6.0%)
- State Street Corpora: 5.1% (-0.5%)
- JPMORGAN CHASE & CO: 2.9% (+83.5%)
- Geode Capital Manage: 2.4% (+2.1%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.18 elevated, pricing in significant growth expectations. Forward P/E 19.3x stretched relative to 8% growth. Quality metrics strong (margin 17%). Insider buying signal ($26.1M), management confidence. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $59.4B |
| Beta | 0.67 |
| 52W Range | $23.94 - $31.48 |
| Short Interest | 2.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.18 |
| Forward P/E | 19.3 |
| Current P/E | 20.8 |
| YoY Growth | 7.8% |
| EPS Direction | STABLE |

### Technicals

MRS_10 improving modestly (+0.7% over 5 days). Below STRENGTH zone by 2.7pp (needs >3.0% for momentum thesis). MRS_5 at 1.1% confirms short-term momentum alignment. Below SMA200 (0.98x), long-term trend not supportive. RSI neutral at 46. OFD pattern: -DLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.27% (CS: 29) | Neutral |
| RSI_14 | 46.1 | Neutral |
| MACD Histogram | -0.06 | Bearish |
| vs SMA20 | 0.988x | Below |
| vs SMA50 | 0.992x | Below |
| vs SMA200 | 0.978x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $26.72
- **Stop Loss:** $25.68 (3.9% risk)
- **Target:** $27.76 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 961
- **Position Value:** $25,677.92
- **Portfolio %:** 25.68%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-01-21 (Est: $0.37)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.30 | $0.29 | -2.8% |
| 2025Q2 | $0.28 | $0.28 | +0.8% |
| 2025Q1 | $0.36 | $0.34 | -4.8% |
| 2024Q4 | $0.33 | $0.32 | -2.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*